Tekla Capital Management’s Medtronic MDT Stock Holding History

Tekla Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$30.3M	Sell	344,417 -100	-0%	-$8.61K	1.19%	20
2023 Q1	$27.8M	Buy	344,517 +18,345	+6%	+$1.5M	1.06%	28
2022 Q4	$25.4M	Hold	326,172	–	–	0.96%	31
2022 Q3	$26.3M	Hold	326,172	–	–	1.08%	28
2022 Q2	$29.3M	Sell	326,172 -108,968	-25%	-$11M	1.15%	26
2022 Q1	$48.3M	Sell	435,140 -70,720	-14%	-$7.47M	1.7%	19
2021 Q4	$52.3M	Sell	505,860 -94,862	-16%	-$11M	1.68%	19
2021 Q3	$75.3M	Buy	600,722 +54,000	+10%	+$6.99M	2.42%	11
2021 Q2	$67.9M	Buy	546,722 +54,508	+11%	+$6.84M	2.21%	14
2021 Q1	$58.1M	Sell	492,214 -42,700	-8%	-$5M	2%	14
2020 Q4	$62.7M	Hold	534,914	–	–	2.2%	10
2020 Q3	$55.6M	Buy	534,914 +59,425	+12%	+$5.97M	2.08%	14
2020 Q2	$43.6M	Buy	475,489 +28,478	+6%	+$2.73M	1.66%	15
2020 Q1	$40.3M	Sell	447,011 -23,801	-5%	-$2.53M	1.82%	12
2019 Q4	$53.4M	Buy	470,812 +71,442	+18%	+$7.84M	2.02%	11
2019 Q3	$43.4M	Sell	399,370 -80,665	-17%	-$8.42M	1.89%	13
2019 Q2	$46.8M	Sell	480,035 -11,967	-2%	-$1.09M	1.91%	13
2019 Q1	$44.8M	Buy	492,002 +10,637	+2%	+$952K	1.82%	14
2018 Q4	$43.8M	Buy	481,365 +141,926	+42%	+$13.3M	1.87%	14
2018 Q3	$33.4M	Sell	339,439 -84,254	-20%	-$7.79M	1.21%	20
2018 Q2	$36.3M	Sell	423,693 -98,518	-19%	-$8.23M	1.38%	18
2018 Q1	$41.9M	Buy	522,211 +16,185	+3%	+$1.33M	1.63%	17
2017 Q4	$40.9M	Sell	506,026 -74,300	-13%	-$5.95M	1.58%	16
2017 Q3	$45.1M	Hold	580,326	–	–	1.61%	17
2017 Q2	$51.5M	Sell	580,326 -32,704	-5%	-$2.76M	1.91%	15
2017 Q1	$49.4M	Sell	613,030 -10,000	-2%	-$781K	1.91%	16
2016 Q4	$44.4M	Hold	623,030	–	–	1.89%	14
2016 Q3	$53.8M	Sell	623,030 -60,674	-9%	-$5.29M	2.07%	13
2016 Q2	$59.3M	Buy	683,704 +126,600	+23%	+$10.2M	2.42%	8
2016 Q1	$41.8M	Buy	557,104 +432,760	+348%	+$32.6M	1.78%	14
2015 Q4	$9.56M	Sell	124,344 -82,700	-40%	-$6.23M	0.35%	62
2015 Q3	$13.9M	Buy	+207,044	New	+$15.2M	0.5%	42

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tekla Capital Management's MDT Position: Q2 2023 in Review

Tekla Capital Management reduced its Medtronic (MDT) stake by 0.03% in Q2 2023, selling an estimated $8.61K and leaving 344,417 shares worth $30.3M. The position accounts for 1.19% of the portfolio, ranked #20.

Tekla Capital Management first reported a position in MDT in Q3 2015 and has held it in 32 quarters since. The position peaked at $75.3M in Q3 2021. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

Tekla Capital Management held 344,417 shares of Medtronic worth $30.3M as of Q2 2023.
Tekla Capital Management sold 100 Medtronic shares in Q2 2023, an estimated $8.61K.
Medtronic made up 1.19% of Tekla Capital Management's portfolio in Q2 2023, its #20 holding.
Tekla Capital Management first reported a position in Medtronic in Q3 2015 and has held it in 32 quarters since.
Tekla Capital Management's Medtronic position peaked at $75.3M in Q3 2021.
2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.